A study of transcriptomic lung cell databases among 52 SSc-ILD patients indicated that the p53-dependent cellular senescence signaling pathway on lung fibroblasts was the major regulatory molecule driving ILD pathology in SSc patients [95]. This evidence concerns the gene TP53 and systemic sclerosis.